DE60036536D1 - Verfahren zur diagnose von endometriose - Google Patents

Verfahren zur diagnose von endometriose

Info

Publication number
DE60036536D1
DE60036536D1 DE60036536T DE60036536T DE60036536D1 DE 60036536 D1 DE60036536 D1 DE 60036536D1 DE 60036536 T DE60036536 T DE 60036536T DE 60036536 T DE60036536 T DE 60036536T DE 60036536 D1 DE60036536 D1 DE 60036536D1
Authority
DE
Germany
Prior art keywords
endometriosis
diagnosis
endometrial
blood
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036536T
Other languages
English (en)
Other versions
DE60036536T2 (de
Inventor
Daniele Gagne
Diane Gosselin
Patrice Hugo
Pierre Miron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Medical Solutions Diagnostics Inc USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Medical Solutions Diagnostics Inc USA filed Critical Siemens Medical Solutions Diagnostics Inc USA
Publication of DE60036536D1 publication Critical patent/DE60036536D1/de
Application granted granted Critical
Publication of DE60036536T2 publication Critical patent/DE60036536T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Devices That Are Associated With Refrigeration Equipment (AREA)
DE60036536T 1999-01-25 2000-01-24 Verfahren zur diagnose von endometriose Expired - Lifetime DE60036536T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11703199P 1999-01-25 1999-01-25
US117031P 1999-01-25
PCT/CA2000/000060 WO2000043789A1 (en) 1999-01-25 2000-01-24 Method and diagnostic kit for diagnosis of endometriosis

Publications (2)

Publication Number Publication Date
DE60036536D1 true DE60036536D1 (de) 2007-11-08
DE60036536T2 DE60036536T2 (de) 2008-06-19

Family

ID=22370639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036536T Expired - Lifetime DE60036536T2 (de) 1999-01-25 2000-01-24 Verfahren zur diagnose von endometriose

Country Status (10)

Country Link
EP (1) EP1147421B1 (de)
JP (1) JP2002535658A (de)
AT (1) ATE374370T1 (de)
AU (1) AU2088800A (de)
BR (1) BR0007702A (de)
CA (1) CA2359200A1 (de)
DE (1) DE60036536T2 (de)
ES (1) ES2292424T3 (de)
NZ (1) NZ513692A (de)
WO (1) WO2000043789A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475298A1 (en) * 2002-02-13 2003-08-21 Kamran Shazand Cd16b as a marker for the diagnosis of endometriosis
US20050100967A1 (en) * 2003-07-11 2005-05-12 Science & Technology Corporation @ Unm Detection of endometrial pathology
US20060008876A1 (en) 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
WO2007031277A2 (en) * 2005-09-14 2007-03-22 Medizinische Universität Wien Means and methods for diagnosing endometriosis
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
EP3215847A4 (de) * 2014-11-03 2018-02-14 Bioincept LLC Pif-bindung als ein marker zur immundysregulierung
US11096987B2 (en) 2015-08-28 2021-08-24 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
EP3341006A4 (de) 2015-08-28 2019-03-13 BioIncept LLC Zusammensetzungen und verfahren zur behandlung von nervenschäden

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
US5618680A (en) * 1994-12-28 1997-04-08 Institut De Medecine De La Reproduction De Montreal Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
CA2265470A1 (en) * 1996-09-06 1998-03-12 Osteometer Biotech A/S Biochemical markers of the human endometrium

Also Published As

Publication number Publication date
CA2359200A1 (en) 2000-07-27
AU2088800A (en) 2000-08-07
NZ513692A (en) 2001-09-28
WO2000043789A1 (en) 2000-07-27
JP2002535658A (ja) 2002-10-22
ATE374370T1 (de) 2007-10-15
DE60036536T2 (de) 2008-06-19
ES2292424T3 (es) 2008-03-16
EP1147421B1 (de) 2007-09-26
EP1147421A1 (de) 2001-10-24
BR0007702A (pt) 2002-09-10

Similar Documents

Publication Publication Date Title
DE59911789D1 (de) Navigationsgerät und verfahren zur positionsbestimmung mittels koppelnavigation
ATE502648T1 (de) Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays
ATE277671T1 (de) Vorrichtung zur verbesserung der transdermalen abnahme von körperflüssigkeiten
DE60029092D1 (de) Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
ATE388132T1 (de) Verfahren zur hydroformylierung von olefinen
DE10196555T1 (de) Systeme und Verfahren zur Entwicklung und Verwaltung von Investmentfonds
ATE420204T1 (de) Verfahren zur detektion von erkrankungen
ATE182216T1 (de) Verfahren zur quantifizierung von lbp in körperflüssigkeiten
ATE193559T1 (de) Verfahren zur diagnose von schizophrenie
DE60306920D1 (de) Vorrichtung zur bestimmung der feinheit von mineralfasern
DE69918349D1 (de) Robustes Verfahren zur Ermittlung der Lagen von Registrierungsmarken
DE60020571D1 (de) Verfahren und vorrichtung zur unterscheidung und zählung von leukozyten
DE60033380D1 (de) Verfahren zur quantifizierung der zahl von leukozyten in einer blutprobe
ATE275882T1 (de) Marker für ein instrument und verfahren zur lokalisation eines markers
ATE374370T1 (de) Verfahren zur diagnose von endometriose
DE3885174D1 (de) Verfahren zur Bewertung von Parametern bezüglich elastischer Eigenschaften von unterirdischen Schichten.
DE59708038D1 (de) Verfahren zur Kennzeichnung von Programmkompatibilität
DE69705478D1 (de) Verfahren zur Identifizierung von Fahrbahnmarkierungen
WO2001098539A3 (en) Gene markers for lung cancer
DE60028114D1 (de) Verfahren zur Analyse von ausgeatmetem Gas
DE60012140D1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
DE50114138D1 (de) Verfahren zur Untersuchung von membranumschlossenen Biokompartimenten
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE69934789D1 (de) Verfahren zur bestimmung der antibiotikasensitivität von bakterien
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC. (N.D.GES.D, US